Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035916 | SCV000059567 | likely benign | not specified | 2014-10-28 | criteria provided, single submitter | clinical testing | p.Leu1505Leu in exon 32 of MYH7: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. |
Color Diagnostics, |
RCV001175853 | SCV001339631 | likely benign | Cardiomyopathy | 2018-11-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002054575 | SCV002427047 | likely benign | Hypertrophic cardiomyopathy | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336115 | SCV002640144 | likely benign | Cardiovascular phenotype | 2022-10-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001723608 | SCV001953044 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001723608 | SCV001967805 | likely benign | not provided | no assertion criteria provided | clinical testing |